Nuria González

发表

Characterization of LEDGF/p75 Genetic Variants and Association with HIV-1 Disease Progression

B. Poppe, P. Messiaen, P. Van Acker, 2012, PloS one.

Safety and immunogenicity of a modified vaccinia Ankara-based HIV-1 vaccine (MVA-B) in HIV-1-infected patients alone or in combination with a drug to reactivate latent HIV-1.

B. Clotet, J. Martinez-Picado, C. Brander, 2015, The Journal of antimicrobial chemotherapy.

Different Expression of Interferon-Stimulated Genes in Response to HIV-1 Infection in Dendritic Cells Based on Their Maturation State

F. Díez-Fuertes, J. Alcamí, R. Le Grand, 2017, Journal of Virology.

Functional characterization of SDF-1 proximal promoter.

F. Arenzana‐Seisdedos, J. Alcamí, N. González, 2005, Journal of molecular biology.

CCR5 structural plasticity shapes HIV-1 phenotypic properties

J. Izopet, Zhicheng Zhou, P. Colin, 2018, PLoS pathogens.

A therapeutic dendritic cell-based vaccine for HIV-1 infection.

B. Clotet, J. Martinez-Picado, J. Romeu, 2011, The Journal of infectious diseases.

A sensitive phenotypic assay for the determination of human immunodeficiency virus type 1 tropism.

S. Spijkers, E. Ruiz-Mateos, M. Leal, 2010, The Journal of antimicrobial chemotherapy.

Broadly Cross-Neutralizing Antibodies in HIV-1 Patients with Undetectable Viremia

J. Alcamí, E. Yuste, J. Alcocer-González, 2011, Journal of Virology.

Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02).

Felipe García, M. Plana, G. Pantaleo, 2011, Vaccine.

Prostratin Induces HIV Activation and Downregulates HIV Receptors in Peripheral Blood Lymphocytes

J. Alcamí, Stephen J Brown, M. Hezareh, 2004, Antiviral therapy.

Detection of Broadly Neutralizing Activity within the First Months of HIV-1 Infection

J. Mascola, J. Alcamí, E. Yuste, 2016, Journal of Virology.

Therapeutic immunization with dendritic cells loaded with heat-inactivated autologous HIV-1 in patients with chronic HIV-1 infection.

Felipe García, M. Plana, A. Cruceta, 2005, The Journal of infectious diseases.

SDF-1/CXCL12 Production by Mature Dendritic Cells Inhibits the Propagation of X4-Tropic HIV-1 Isolates at the Dendritic Cell-T-Cell Infectious Synapse

Q. Sattentau, C. Jolly, F. Arenzana‐Seisdedos, 2010, Journal of Virology.

Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequence

John P. Moore, M. V. van Breemen, I. Wilson, 2019, Nature Communications.

Guatemalan plants extracts as virucides against HIV-1 infection.

A. Cáceres, L. Bedoya, A. Álvarez, 2008, Phytomedicine : international journal of phytotherapy and phytopharmacology.

Guidelines for cloning, expression, purification and functional characterization of primary HIV-1 envelope glycoproteins.

P. Colin, F. Arenzana‐Seisdedos, I. Staropoli, 2016, Journal of virological methods.

Potent Induction of Envelope-Specific Antibody Responses by Virus-Like Particle Immunogens Based on HIV-1 Envelopes from Patients with Early Broadly Neutralizing Responses

À. Olvera, C. Brander, R. Sanders, 2021, Journal of virology.

HIV-1 exploits CCR5 conformational heterogeneity to escape inhibition by chemokines

P. Colin, A. Brelot, O. Hartley, 2013, Proceedings of the National Academy of Sciences.

A cell-to-cell HIV transfer assay identifies humoral responses with broad neutralization activity.

B. Clotet, Felipe García, J. Gatell, 2011, Vaccine.

c/EBPbeta is a major regulatory element driving transcriptional activation of the CXCL12 promoter.

L. Mestre, J. Alcamí, J. Pablos, 2010, Journal of molecular biology.

Association between stromal cell-derived factor 1 chemokine gene variant and radiographic progression of rheumatoid arthritis.

J. Alcamí, J. Pablos, B. Santiago, 2005, Arthritis and rheumatism.

Hydroxytyrosol: a new class of microbicide displaying broad anti-HIV-1 activity

L. Bedoya, J. Alcamí, M. Pérez-Olmeda, 2016, AIDS.